Categories Earnings, Health Care, LATEST

Amgen beats in Q3, raises guidance

Amgen Inc (NASDAQ: AMGN) reported third-quarter 2019 adjusted EPS of $3.66 on revenue of $5.74 billion. This was better than analysts’ prediction of earnings of $3.53 per share on revenues of $5.63 billion. Amgen stock advanced about 0.2% during the after-hours.

Revenues for the quarter reflected a 3% decline over last year, due to the impact of biosimilar and generic competition against key products. Total product sales edged down 1%.Amgen (AMGN) Q3 2019 earnings results

CEO Robert Bradway said, “We continue to advance numerous first-in-class medicines in our pipeline, while also pursuing external opportunities that will contribute to our long-term growth, such as our pending acquisition of Otezla.”

Amgen raised its outlook on full-year 2019 revenue to a range of $22.8 billion – $23.0 billion, from the earlier range of $22.4 billion – $22.9 billion. The company also raised the guidance on GAAP and Non-GAAP earnings.

Amgen currently expects full year adjusted EPS of $14.20 to $14.45, versus the prior estimate of  $13.75 to $14.30. On a GAAP basis, Amgen is projected to earn $12.50 to $12.80 in fiscal 2019, higher than the initial projection of $12.10 to $12.71

READ: After a 2-month stock slide, Q3 could bring Alteryx’s deflection point

Rival drugmaker Pfizer (NYSE: PFE) yesterday reported lower revenues and earnings for the third quarter. The results, however, topped the market’s expectations.  Merck (NYSE: MRK) also surpassed analysts’ expectations yesterday helped by oncology and vaccines.

The quarterly results come two months after Amgen announced that it would acquire Celgene’s (NASDAQ: CELG) Otezla business for $13.4 billion in a cash transaction. Amgen expects the addition of OTEZLA to positively impact its financial results, including an immediate accretion to its non-GAAP EPS.

AMGN shares have gained 8% since the beginning of this year and 11% in the past 12 months.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

Does Unity Software (U) stock has more room to run?

Last month, the IPO market was in a full swing. IPOs of Snowflake (NYSE: SNOW) and JFROG (NASDAQ: FROG) had an impressive opening day in September, the former creating a

PepsiCo (PEP): Steady snacking habits amid pandemic drive strong quarter for beverage giant

PepsiCo Inc. (NASDAQ: PEP) beat market expectations on both revenue and earnings for the third quarter of 2020. The company saw the momentum continue in its snacks business while the

Does the virus-driven boom make Electronic Arts (EA) a good investment?

With more and more people turning to virtual entertainment sources, amid the virus-related movement restrictions, video game publishers like Electronic Arts (NASDAQ: EA) are witnessing unusually high demand. Not surprisingly,

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top